Taiyen Biotech Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Shi-Hui Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4yrs |
| CEO ownership | n/a |
| Management average tenure | 2.2yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20
Jul 31
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality
May 09Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher
Apr 09A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Mar 25Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?
Mar 12Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?
Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend
Feb 01Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)
Jan 04A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Dec 22How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?
Dec 09Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return
Nov 24CEO
Shi-Hui Chen
4yrs
Tenure
Mr. Shi-Hui Chen serves as President at Taiyen Biotech Co., Ltd. since 2021. He served as Vice President of Taiyen Biotech Co., Ltd.He served as Spokesperson of Taiyen Biotech Co., Ltd. He served as Direc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4yrs | no data | no data | |
| Director of Financial Accounting Department | no data | no data | no data | |
| Director of Administrative Department & Representative Director | less than a year | no data | no data | |
| Director of Legal Affairs Office | no data | no data | no data | |
| VP & Director of Corporate Development Department | no data | no data | 0.00089% NT$ 56.2k | |
| Director of Branding & Marketing Department | no data | no data | no data | |
| Chief Internal Auditor | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Management: 1737's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director of Administrative Department & Representative Director | less than a year | no data | no data | |
| Chairman of the Board | less than a year | no data | no data | |
| Director | no data | no data | no data | |
| Director | 5.6yrs | no data | no data | |
| Independent Director | 5.6yrs | no data | no data | |
| Independent Director | 5.6yrs | no data | no data | |
| Independent Director | 5.6yrs | no data | no data | |
| Independent Director | 2.5yrs | no data | no data | |
| Independent Director | 2.5yrs | no data | no data | |
| Independent Director | 1.6yrs | no data | no data | |
| Representative Director | 1.5yrs | no data | no data |
2.5yrs
Average Tenure
Experienced Board: 1737's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/18 02:29 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Taiyen Biotech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | E.Sun Securities Investment Consulting Co. Ltd. |
| Titan Horng | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |